Medicine & Life Sciences
Liver Transplantation
100%
Hepacivirus
20%
Hepatitis C
19%
Graft Survival
18%
Atrial Fibrillation
17%
obeticholic acid
16%
Hepatitis B
16%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
15%
Survival
14%
telaprevir
14%
Fibrosis
14%
Transplants
13%
Liver
13%
Takotsubo Cardiomyopathy
13%
Tissue Donors
13%
Physician Assistants
12%
Sclerosing Cholangitis
12%
Autoimmune Hepatitis
12%
Hepatitis Viruses
12%
End Stage Liver Disease
11%
Chronic Hepatitis B
11%
Biliary Liver Cirrhosis
11%
Nurse Practitioners
11%
Patient Readmission
11%
Recurrence
11%
Ribavirin
10%
Fatty Liver
10%
Left Ventricular Dysfunction
10%
Liver Diseases
10%
Allografts
9%
Transplantation
9%
Cardiomyopathies
9%
Palliative Care
9%
Case-Control Studies
8%
Chronic Disease
8%
Hepatocellular Carcinoma
7%
Vaccination
7%
Retrospective Studies
7%
Virus Diseases
7%
Genotype
6%
Placebos
6%
Interviews
6%
Antiviral Agents
6%
Infections
5%